| 1 | Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes : A Mediation Analysis. (Agarwal R, Tu W, Farjat AE, Farag YMK, Toto R, Kaul S, Lawatscheck R, Rohwedder K, Ruilope LM, Rossing P, Pitt B, Filippatos G, Anker SD, Bakris GL, FIDELIO-DKD and FIGARO-DKD Investigators) Ann Intern Med 2023 Dec;176(12):1606-1616 3 Citations |
| 1 | Clinical trials with reno-vascular end points in patients with diabetes: Changing the scenario over the past 20 years. (Block TJ, Cooper ME) Presse Med 2023 Mar;52(1):104178 1 Citation |
| 1 | Protease-Activated Receptor 1-Mediated Damage of Podocytes in Diabetic Nephropathy. (Bohovyk R, Khedr S, Levchenko V, Stefanenko M, Semenikhina M, Kravtsova O, Isaeva E, Geurts AM, Klemens CA, Palygin O, Staruschenko A) Diabetes 2023 Dec 01;72(12):1795-1808 2 Citations |
| 1 | Knockout of Matrix Metalloproteinase 2 Opposes Hypertension- and Diabetes-induced Nephropathy. (Hirata T, Fan F, Fan L, Amin G, White T, Geurts AM, Kojima N, Takahashi T, Miyata N, Williams J, Roman RJ) J Cardiovasc Pharmacol 2023 Dec 01;82(6):445-457 1 Citation |
| 1 | Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium-Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis. (Rossing P, Anker SD, Filippatos G, Pitt B, Ruilope LM, Birkenfeld AL, McGill JB, Rosas SE, Joseph A, Gebel M, Roberts L, Scheerer MF, Bakris GL, Agarwal R, FIDELIO-DKD and FIGARO-DKD Investigators) Diabetes Care 2022 Dec 01;45(12):2991-2998 58 Citations |
| 1 | Simultaneous Pancreas-kidney Transplantation for Type 2 Diabetes Mellitus. (Singh N, Parsons R, Lentine KL, Woodside KJ, Basu A, Cheungpasitporn W, Kensinger C, Parajuli S, Rivera FHC, Sultan S, Tantisattamo E, Zibari G, Pavlakis M, Cooper M) Transplantation 2021 Aug 01;105(8):e91-e92 3 Citations |
| 1 | Characterization of the Peritumoral Atrophic Band and Nonneoplastic Renal Parenchyma in Radical Nephrectomy Specimens. (Dernell C, Bhasin B, Iczkowski KA, Gallan AJ) Am J Clin Pathol 2021 Oct 13;156(5):913-919 |
| 2 | The relationship between financial hardship and incident diabetic kidney disease in older US adults - a longitudinal study. (Corwin TR, Ozieh MN, Garacci E, Palatnik A, Egede LE) BMC Nephrol 2021 May 05;22(1):167 3 Citations |
| 1 | Sexual dimorphism in the progression of type 2 diabetic kidney disease in T2DN rats. (Spires DR, Palygin O, Levchenko V, Isaeva E, Klemens CA, Khedr S, Nikolaienko O, Kriegel A, Cheng X, Yeo JY, Joe B, Staruschenko A) Physiol Genomics 2021 Jun 01;53(6):223-234 8 Citations |
| 2 | The cumulative impact of social determinants of health factors on mortality in adults with diabetes and chronic kidney disease. (Ozieh MN, Garacci E, Walker RJ, Palatnik A, Egede LE) BMC Nephrol 2021 Feb 28;22(1):76 18 Citations |
| 2 | NOX4-dependent regulation of ENaC in hypertension and diabetic kidney disease. (Pavlov TS, Palygin O, Isaeva E, Levchenko V, Khedr S, Blass G, Ilatovskaya DV, Cowley AW Jr, Staruschenko A) FASEB J 2020 Oct;34(10):13396-13408 18 Citations |
| 1 | Assessment of venous congestion by Doppler ultrasound: a valuable bedside diagnostic tool for the new-age nephrologist. (Mahmud S, Koratala A) CEN Case Rep 2021 Feb;10(1):153-155 9 Citations |
| 1 | Endogenous miR-204 Protects the Kidney against Chronic Injury in Hypertension and Diabetes. (Cheng Y, Wang D, Wang F, Liu J, Huang B, Baker MA, Yin J, Wu R, Liu X, Regner KR, Usa K, Liu Y, Zhang C, Dong L, Geurts AM, Wang N, Miller SS, He Y, Liang M) J Am Soc Nephrol 2020 Jul;31(7):1539-1554 50 Citations |
| 1 | Progression of diabetic kidney disease in T2DN rats. (Palygin O, Spires D, Levchenko V, Bohovyk R, Fedoriuk M, Klemens CA, Sykes O, Bukowy JD, Cowley AW Jr, Lazar J, Ilatovskaya DV, Staruschenko A) Am J Physiol Renal Physiol 2019 Dec 01;317(6):F1450-F1461 35 Citations |
| 3 | Insulin therapy in patients with type 2 diabetes and high insulin resistance is associated with increased risk of complications and mortality. (Mendez CE, Walker RJ, Eiler CR, Mishriky BM, Egede LE) Postgrad Med 2019 Aug;131(6):376-382 14 Citations |
| 1 | A promising outlook for diabetic kidney disease. (Cooper M, Warren AM) Nat Rev Nephrol 2019 Feb;15(2):68-70 23 Citations |
| 1 | Inactivation of p66Shc Decreases Afferent Arteriolar KATP Channel Activity and Decreases Renal Damage in Diabetic Dahl SS Rats. (Miller BS, Blumenthal SR, Shalygin A, Wright KD, Staruschenko A, Imig JD, Sorokin A) Diabetes 2018 Nov;67(11):2206-2212 11 Citations |
| 1 | Ipsilateral versus contralateral placement of the pancreas allograft in pancreas after kidney transplant recipients. (Yin H, Arpali E, Leverson GE, Sollinger HW, Kaufman DB, Odorico JS) Clin Transplant 2018 Aug;32(8):e13337 5 Citations |
| 2 | Protective role of Trpc6 knockout in the progression of diabetic kidney disease. (Spires D, Ilatovskaya DV, Levchenko V, North PE, Geurts AM, Palygin O, Staruschenko A) Am J Physiol Renal Physiol 2018 Oct 01;315(4):F1091-F1097 45 Citations |
| 1 | Not all kidney disease in patients with diabetes is diabetic nephropathy. (Koratala A, Chamarthi G, Maska E, Clapp WL) Intern Emerg Med 2018 Oct;13(7):1131-1132 |
| 2 | A NOX4/TRPC6 Pathway in Podocyte Calcium Regulation and Renal Damage in Diabetic Kidney Disease. (Ilatovskaya DV, Blass G, Palygin O, Levchenko V, Pavlov TS, Grzybowski MN, Winsor K, Shuyskiy LS, Geurts AM, Cowley AW Jr, Birnbaumer L, Staruschenko A) J Am Soc Nephrol 2018 Jul;29(7):1917-1927 92 Citations |
| 2 | Independent correlates of chronic kidney disease awareness among adults with type 2 diabetes. (Obadan NO, Walker RJ, Egede LE) J Diabetes Complications 2017 Jun;31(6):988-991 10 Citations |
| 1 | Anti-TGF-β1 Antibody Therapy in Patients with Diabetic Nephropathy. (Voelker J, Berg PH, Sheetz M, Duffin K, Shen T, Moser B, Greene T, Blumenthal SS, Rychlik I, Yagil Y, Zaoui P, Lewis JB) J Am Soc Nephrol 2017 Mar;28(3):953-962 201 Citations |
| 1 | Unilateral pleural effusion in a peritoneal dialysis patient. (Koratala A, Bhatti V) BMJ Case Rep 2016 Sep 08;2016 |
| 1 | Calciphylaxis of the breast: a rare metabolic complication of kidney disease. (Koratala A, Ejaz AA, Mohandas R) BMJ Case Rep 2016 Aug 09;2016 8 Citations |
| 2 | Medical care expenditures associated with chronic kidney disease in adults with diabetes: United States 2011. (Ozieh MN, Dismuke CE, Lynch CP, Egede LE) Diabetes Res Clin Pract 2015 Jul;109(1):185-90 41 Citations |
| 1 | Lipotoxic disruption of NHE1 interaction with PI(4,5)P2 expedites proximal tubule apoptosis. (Khan S, Abu Jawdeh BG, Goel M, Schilling WP, Parker MD, Puchowicz MA, Yadav SP, Harris RC, El-Meanawy A, Hoshi M, Shinlapawittayatorn K, Deschênes I, Ficker E, Schelling JR) J Clin Invest 2014 Mar;124(3):1057-68 45 Citations |
| 1 | The impact of diabetes on ethnic disparities seen in kidney transplantation. (Taber DJ, Meadows HB, Pilch NA, Chavin KD, Baliga PK, Egede LE) Ethn Dis 2013;23(2):238-44 8 Citations |
| 1 | Evolution of treatment for diabetic nephropathy: historical progression from RAAS inhibition and onward. (Blumenthal SS) Postgrad Med 2011 Nov;123(6):166-79 10 Citations |
| 1 | Pyridorin in type 2 diabetic nephropathy. (Lewis EJ, Greene T, Spitalewiz S, Blumenthal S, Berl T, Hunsicker LG, Pohl MA, Rohde RD, Raz I, Yerushalmy Y, Yagil Y, Herskovits T, Atkins RC, Reutens AT, Packham DK, Lewis JB, Collaborative Study Group) J Am Soc Nephrol 2012 Jan;23(1):131-6 125 Citations |
| 1 | Evaluation of metalloprotease inhibitors on hypertension and diabetic nephropathy. (Williams JM, Zhang J, North P, Lacy S, Yakes M, Dahly-Vernon A, Roman RJ) Am J Physiol Renal Physiol 2011 Apr;300(4):F983-98 41 Citations |
| 1 | Prevention of diabetic nephropathy in Ins2(+/)⁻(AkitaJ) mice by the mitochondria-targeted therapy MitoQ. (Chacko BK, Reily C, Srivastava A, Johnson MS, Ye Y, Ulasova E, Agarwal A, Zinn KR, Murphy MP, Kalyanaraman B, Darley-Usmar V) Biochem J 2010 Nov 15;432(1):9-19 191 Citations |
| 1 | Genetic analysis of albuminuria in aging mice and concordance with loci for human diabetic nephropathy found in a genome-wide association scan. (Tsaih SW, Pezzolesi MG, Yuan R, Warram JH, Krolewski AS, Korstanje R) Kidney Int 2010 Feb;77(3):201-10 37 Citations |
| 1 | Activated protein C protects against diabetic nephropathy by inhibiting endothelial and podocyte apoptosis. (Isermann B, Vinnikov IA, Madhusudhan T, Herzog S, Kashif M, Blautzik J, Corat MA, Zeier M, Blessing E, Oh J, Gerlitz B, Berg DT, Grinnell BW, Chavakis T, Esmon CT, Weiler H, Bierhaus A, Nawroth PP) Nat Med 2007 Nov;13(11):1349-58 346 Citations |
| 1 | Matrix metalloproteinase-2 dysregulation in type 1 diabetes. (Thrailkill KM, Bunn RC, Moreau CS, Cockrell GE, Simpson PM, Coleman HN, Frindik JP, Kemp SF, Fowlkes JL) Diabetes Care 2007 Sep;30(9):2321-6 96 Citations |
| 1 | Urine biomarkers predict the cause of glomerular disease. (Varghese SA, Powell TB, Budisavljevic MN, Oates JC, Raymond JR, Almeida JS, Arthur JM) J Am Soc Nephrol 2007 Mar;18(3):913-22 206 Citations |
| 1 | Glucose screening and the risk of complications in Type 2 diabetes mellitus. (Schellhase KG, Koepsell TD, Weiss NS, Wagner EH, Reiber GE) J Clin Epidemiol 2003 Jan;56(1):75-80 15 Citations |
| 1 | Acute torsion of the renal transplant after combined kidney-pancreas transplant. (Roza AM, Johnson CP, Adams M) Transplantation 1999 Feb 15;67(3):486-8 27 Citations |
| 1 | Recurrent and de novo renal diseases after renal transplantation: a report from the renal allograft disease registry. (Hariharan S, Peddi VR, Savin VJ, Johnson CP, First MR, Roza AM, Adams MB) Am J Kidney Dis 1998 Jun;31(6):928-31 116 Citations |
| 1 | Susceptibility genes for end-organ damage. New strategies to understand diabetic and hypertensive nephropathy. (Broeckel U, Shiozawa M, Kissebah AH, Provoost AP, Jacob HJ) Nephrol Dial Transplant 1998 Apr;13(4):840-2 4 Citations |
| 1 | Strategies for preventing diabetic nephropathy. (Raymond JR, Arthur JM, Kovalik E) N C Med J 1994 Aug;55(8):362-9 |
| 1 | The excess incidence of diabetic end-stage renal disease among blacks. A population-based study of potential explanatory factors. (Brancati FL, Whittle JC, Whelton PK, Seidler AJ, Klag MJ) JAMA 1992 Dec 02;268(21):3079-84 191 Citations |
| 1 | Choice of urine sample predictive of microalbuminuria in patients with insulin-dependent diabetes mellitus. (Ellis D, Coonrod BA, Dorman JS, Kelsey SF, Becker DJ, Avner ED, Orchard TJ) Am J Kidney Dis 1989 Apr;13(4):321-8 98 Citations |
| 1 | A randomized trial comparing cyclosporine with antilymphoblast-globulin-azathioprine for renal allograft recipients. Results at 2 1/2-6 years. (Johnson CP, Simmons RL, Sutherland DE, Canafax DM, Ascher NL, Payne WD, Flick B, Najarian JS, Fryd DS) Transplantation 1988 Feb;45(2):380-5 11 Citations |
| 1 | SEM studies of acellular glomerular basement membrane in human diabetic glomerulopathy. (Carlson EC, Surerus KK) Anat Rec 1986 Nov;216(3):349-58 13 Citations |
| 1 | Ultrastructural analysis of major basement membrane types in rhesus monkey Macaca mulatta acellular renal cortex. (Carlson EC, Surerus KK, Hinds D) Acta Anat (Basel) 1986;125(1):14-22 8 Citations |
| 1 | Diabetic nephropathy in adolescence: appearance during improved glycemic control. (Ellis D, Avner ED, Transue D, Yunis EJ, Drash AL, Becker DJ) Pediatrics 1983 May;71(5):824-9 16 Citations |
